Beovu, but not Lucentis impairs the function of the barrier formed by retinal endothelial cells in v...
Beovu, but not Lucentis impairs the function of the barrier formed by retinal endothelial cells in vitro
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Because rare, but severe adverse effects, i.e. retinal vasculitis or retinal vein occlusion, have been observed after repetitive intravitreal injections of VEGF-A-binding single-chain variable fragment brolucizumab (Beovu), we investigated its possible impact on the barrier formed by immortalized bovine retinal endothelial cells (iBREC) in comparis...
Alternative Titles
Full title
Beovu, but not Lucentis impairs the function of the barrier formed by retinal endothelial cells in vitro
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_489b5d3c620344e6953c3e9f9f7f0134
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_489b5d3c620344e6953c3e9f9f7f0134
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-022-16770-7
